RecruitingUlcerative Colitis (UC)
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Eligible age
18–75 yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XmAb942 in healthy volunteers (Parts A and B). Part C of this study will be a Phase 2 study to evaluate XmAb942 in participants with ulcerative colitis (UC).
Sponsor: Xencor, Inc.
You may qualify if…
- ✓ Parts A and B
- ✓ Age 18-55
- ✓ Must be in good health with no significant medical history
- ✓ Clinical laboratory values within normal range
- ✓ BMI 18-35 (inclusive)
- ✓ Contraceptive use by men or women consistent with local regulations
- ✓ Able and willing to provide written informed consent
- ✓ Part C
You may not qualify if…
- ✕ Parts A and B
- ✕ Any physical or psychological condition that prohibits study completion
- ✕ History of suicidal behavior or suicidal ideation
- ✕ Heavy use of nicotine containing products
- ✕ HIV, hepatitis B and hepatitis C positive
- ✕ Cardiac arrhythmia, or clinically significant abnormal ECG
- ✕ Active use of prescription medications within 14 days of Day -1
- ✕ Active use of over-the-counter, or herbal medication within 7 days of Screening
Where it's recruiting
Arizona
Scottsdale
California
Palo Alto
Florida
Bradenton · Brandon · Jacksonville · Kissimmee …
Kentucky
Louisville
Mississippi
Oxford · Tupelo
New York
Albany · Rochester
North Carolina
Raleigh
Ohio
Beavercreek
Tennessee
Cordova
Texas
Cedar Park · Denton · Garland · Georgetown …
Virginia
Richmond
Source: ClinicalTrials.gov · NCT06619990 · last updated 2026-10-30